Fibrin tissue adhesives

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 661-666

  Martinowitz, Uri ^a   Spotnitz, William D ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMINOCAPROIC ACID; ANTIPLASMIN; APROTININ; BLOOD CLOTTING FACTOR 8; FIBRIN; FIBRIN GLUE; FIBRINOGEN; FIBRONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBIN; THROMBOSPONDIN; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ANAPHYLAXIS; BLEEDING; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CRYOPRECIPITATE; DRUG FORMULATION; DRUG MECHANISM; FIBRINOLYSIS; HEMOSTASIS; HUMAN; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; QUADRIPLEGIA; THROMBOGENESIS; VIRUS INACTIVATION;

EID: 0030857065     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657608     Document Type: Conference Paper

References (70)

1. Bergel S: Uber Wirkungen des Fibrins. Dtsch Med Wochenschr 1909;35:633.
2. Podoshin L, Fradis M, Ben David J, Malatskey S. Results of surgery for chronic otitis media: a 5 year study. Rev Laryngol Rhinol(Bord) 1995;116:109-13.
3. Schwarz N, Redl H, Zeng L, Schlag G, Dinges HP, Eschberger J. Early osteoinduction in rats is not altered by fibrin sealant. Clin Orthop 1993;293:353-9.
4. Milne AA, Murphy WG, Reading SJ, Ruckley CV. Fibrin sealant reduces suture line bleeding during carotid endarterectomy: a randomized trial. Eur J Vaso Endovasc Surg 1995;10:91-4.
5. Kohno H, Nagasue N, Chang Y-C, Taniura H, Yamanoi A, Nakamura T. Comparison of topical hemostatic agents in elective hepatic resection: a clinical prospective randomized trial. World J Surg 1992;16:966-70
6. Byrne DJ, Hardy J, Wood RA, McIntosh R, Hopwood D, Cuschieri A. Adverse influence of fibrin sealant on the healing of high risk sutured colonic nastomoses. J R Coll Surg Edinb 1992;37:394-98.
7. Van der Ham AC, Kort WJ, Weijma IM, van den Ingh FG, Jeekel H. Effect of fibrin sealant on the integrity of colonic anastomoses in rats with faecal peritonitis. Eur J Surg 1993;159:425-32.
8. Moore MM, Nguyen DHD, Spotnitz WD. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg 1997;63:97-102.
9. Vaxman F, Kolbe A, Stricher F, Zund D, Volkmar P, Gros D, Grenier JF. Does fibrin glue improve drainage after axillary lymph node dissection? Eur Surg Res 1995;27:346-52.
10. Alving BM, Weinstein MJ, Finlayson JS, Menitov JE, Fratantoni JC. Fibrin sealant: summary of a conference on characteristics and clinical uses. Transfusion 1995;35:783-90.
11. Salz R, Dimick A, Harris C, Grotting JC, Psillakis J, Vasconez LO. Application of autologous fibrin glue in bum wound. J Burn Care Rehabil 1989;10:504-7.
12. Hartman AR, Galanakis DK, Honig MP, Seifert FC, Anagnostopoulus CA. Autologous whole plasma fibrin glue. Arc Surg 1992;127:357-9.
13. OzMC, Jeevanandam V, Smith CR, Williams MR, Kaynar AM, Frank RA, Mosca R, Reiss RF, Rose EA. Autologous fibrin glue from intraoperatively collected platelet-rich plasma. Ann Thorac Surg 1992;53:530-1.
14. Rock G, Berger R, Lange J, Gosselin R. A novel, automated method of cryoprecipitation to general an autologous fibrin glue (abst.). Thromb Haemost 1997; in press
15. Amery MJ, Edwardson PA, Fairbrother JE, Hollingsbee I, Holm NE, Westwood B, Cederholm-Williams SA. The first totally autologous fibrin sealant which does not require added thrombin (abst.) Thromb Haemost 1995;73:1463.
16. Prunkard D, Holly R, Cottingham I, Garner I, Lasser G, Bishop P, Foster D. Heterologous production of recombinant human fibrinogen, thrombin, and factor XIII as components of completely recombinant fibrin sealants(abst.) Thromb Haemost 1997; in press
17. Pipan CM, Glasheen WP, Matthew TL, Gonias SL, Hwang LJ, Jane JA, Spotnitz WD. Effects of antifibrinolytic agents on the life span of fibrin sealant. J Surg Res 1992;53:402-7.
18. Rakocz M, Mazar A, Varon D, Spierer S, Blinder D, Martinowitz U. Dental extractions in patients with bleeding disorders: the use of fibrin glue. Oral Surg Oral Med Oral Pathol 1993;75:280-2.
19. Schiele U, Kuntz G, Riegler A. Fixed combination of fibrin glue with a sheet of collagen: a 'ready-to-use' local haemostyptic agent. Surg Tech Internat 1991;1:120.
20. Cornum R, Gresham V, Bell J, Tuthill D, Drohan W, MacPhee M. Evaluation of an absorbable fibrin adhesive bandage in canine radical prostatectomies. (abst.) Thromb Haemost 1997; in press
21. Cottingham I, McKee C, McCreath G. Fully recombinant fibrin sealant using human fibrinoge from transgenic sheep. (abst.) Thromb Haemost 1997; in press
22. Butler S, Vancott K, Gwazdauskas F, Lubon H, Drohan W, Velander W. The production of recombinant fibrinogen in the milk of transgenic animals, (abst.) Thromb Haemost 1997; in press
23. Bale L.G, Westrick L.G, Mosher D.F. Incorporation of thrombospondin into fibrin clots. J Biol Chem 1985;260:7502-8.
24. Weatherford DA, Sackman JE, Reddick TT, Freeman MB, Stevens SL, Goldman MH. Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition. Surgery 1996;120:433-9.
25. Kjaergard HK, Weis-Fogh US. Important factors influencing the strength of autologous fibrin glue: the fibrin concentration and reaction time. Comparison of strength with commercial fibrin glue. Eur Surg Res 1994;26:273-6.
26. Siedentop KH, Park JJ, Sanchez B. An autologous fibrin tissue adhesive with greater bonding power. Arch Otolaryngol Head Neck Surg 1995; 121:769-72.
27. Nur I, Lushkov G, Lachovetzky Y, Shoshani E. "Fibrin Glue" is not a generic product-comparison of hemostatic effect and adhesion formation with fibrin vs. cryo based sealant, (abst.) Thromb Haemost 1997; in press
28. Amrani DL, DiOrio JP, Delmotte Y, Krack GF, White R. In vitro characterization and structural basis for in vivo efficacy of fibrin sealant in preventing formation of surgical adhesions. (abst.) Thromb Haemost 1997; in press
29. Delmotte Y, Krack GF, Amrani DL, DiOrio JP, White R. In vivo efficacy of fibrin sealant" applied as a sprayed glue or film in preventing post surgical adhesions, (abst.) Thromb Haemost 1997; in press
30. van Gelder J.M, Nair C.H, Dhall D.P. Colloid determination of fibrin network permeability. Blood Coag.and Fibrin 7:747-60.
31. Hoots K, McLeod J, Eqqers E, Berg J, Lee M, Gomperts E. Pilot study to evaluate efficacy of fibrin sealant(human) on hemostasis in hemophiliacs undergoing tooth extraction (abst.) Blood 1993;82:598.
32. Achauer BM, Miller SR, Lee TE. The hemostatic effect of fibrin glue on graft donor sites. J Burn Care Rehabil 1994;15:24-8.
33. Suzuki Y, Kuroda Y, Monta A, Fujimo Y, Tanoika Y, Kawamura T, Saiton V. Fibrin glue sealing for the prevention of pancreatic fisulas following distal pancreatectomy. Arch Surg 1995;130:952-5.
34. D'andrea AA, Costantino V, Sperti C, Pedrazzoli S. Human fibrin sealant in pancreatic surgery: a prospective randomized study. Ital J Gastroenterol 1994;26:283-6.
35. Povisen B. A new fibrin seal: functional evaluation of sensory regeneration following primary repair of peripheral nerves. J Hand Surg Br 1994;19:250-4.
36. Bento RF, Miniti A. Anastomosis of the intratemporal facial nerve using fibrin tissue adhesive. Ear Nose Throat J. 1993;72:663-7.
37. Martinowitz U, Saltz R. Fibrin sealant. Curr Opin Hematol 1996;3:395-402.
38. Jackson M.R, MacPhee M.J, Drohan W.N, Alving B.M. Fibrin sealant:current and potential clinical applications. Blood Coagulation and Fibrinolysis 1996;7:737-46.
39. Ismail S, Combs MJ, Goodman NC, Teotia SS, Teates CD, Abbott RD, Fechner RE, Nolan SP, Powers ER, Spotnitz WD. Reduction of femoral arterial bleeding post catheterization using percutaneous application of fibrin sealant. Cathet Cardiovasc Diagn 1995;34:88-95.
40. Bayfield MS, Spotnitz WD. Fibrin sealant in thoracic surgery: pulmonary applications, including management of bronchopleural fistula. Chest Surg Clin North Am 1996;6:567-83
41. Hillerdal G, Gustafsson G, Wegenius G, Englesson S, Hedenstrom H, Hedenstierna G. Large emphysematous bullae: successful treatment with thoracoscopic technique using fibrin glue in poor-risk patients. Chest 1995;107:1450-3.
42. Samuels LE, Shaw PM, Blaum LC Jr. Percutaneous technique for management of persistent airspace with prolonged air leak using fibrin glue. Chest 1996;109:1653-5.
43. Salvino CK, Esposito TJ, Smith DK, Jacobs HK, Candel AG, Dries D, Gamelli R. Laparoscopic injection of fibrin glue to arrest intraparenchymal abdominal hemorrhage: an experimental study. J Trauma 1993;35:762-6.
44. Lau WY, Leung KL, Zhu XL, Lam YH, Chung SC. Laparoscopic repair of perforated peptic ucler. Br J Surg 1995;82:814-16.
45. Jones DB, Brewer JD, Meininger TA, Soper NJ. Sutured of fibrin glue laparoscopic choledochojejunostomy. Surg Endosc 1995;9:1020-7.
46. Boyce ST, Holder IA, Supp AP, Warden GD, Greenhalgh DG. Delivery and acivity of antimicrobial drugs released from human fibrin sealant. J Burn care Rehabil 1994;15:251-5.
47. Deyerling W, Haverich A, Potel J, Hetzer R. A suspension of fibrin glue and antibiotic for local treatment of myocotic aneurysms in endocarditis-an experimental study. Thorac Cardiovasc Surg 1984;32:369-72.
48. Zilch H, Lambiris E. The sustained of cefotaxim from a fibrin cefotaxin compond in treatment of osteitis. Arch Ortho Trauma Surg 1986;106:36-41.
49. Haverich A, Hirt S, Karck M, Siclari F, Wahlig H. Prevention of graft infection by bonding of gentamycin to Dacron prostheses. J Vasc Surg 1992:15:187-93.
50. Kuriansky J, Bass A, Keller N, Ayalon A, Martinowitz U. Fibrin glue antibiotic suspension in the prevention of vascular graft infection. (abst.) Thromb Haemost 1997; in press
51. Woolverton C.J, Dorhan W.N, MacPhee M. Antibiotic delivered in fibrin subvert bacterial resistance. (abst.) Thromb Haemost 1997; in press
52. Kabuto M, Kubota T, Kobayashi H, Nakagawa T, Arai Y, Kitai R. Experimental study of intraoperative local chemotherapy with fibrin glue containing nitrosourea for malignant gliomas. Surg Neuro 1995;44:151-7.
53. Lasa C, Hollinger J, Drohan W, MacPhee M. Delivery of demineralized bone powder by fibrin sealant. Plast Reconstr Surg 1995;96:1409-18.
54. Kang SS, Gosselin C, Ren D, Greisler HP. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor 1 plus heparin delivered from fibrin glue suspensions. surgery 1995;118:280-7.
55. Martinowitz U, Varon D, Yonash P, Bar-Maor A, Brenner B, Leibovitch I, Heim M. Circumcision in hemophilia: the use of fibrin glue for local hemostasis. J Urol 1992;148:855-7.
56. Martinowitz U, schulman S. Fibrin sealant in surgery of patients with a hemorrhagic diathesis. Thrornb Haemost 1995;74:486-92.
57. Horoszowski H, Heim M, Schulman S, Varon D, Martinowitz U. Multiple joint procedures in a single operative session on hemophilic patients. ClinOrth Rel Res. 1996; 328:60-4.
58. O. Levy, U. Martinowitz, D. Murray, R. Crowford, H. Horoszowski. The use of fibrin tissue adhesive reduces intraoperative and post operative blood loss in total hip arthroplasty surgery-preliminary report. Thromb Haemost 1997; in press
59. Ochsner MG, Maniscalco-Theberge ME, Champion HR. Fibrin glue as a hemostatic agent in hepatic and splenic trauma. J Trauma 1990;30:884-7.
60. Berguer R, Staerkel RL, Moore EE, Moore FA, Galloway WB, Mockus MB. Warning:fatal reaction to the use of fibrin glue in deep hepatic wounds. Case report. J Trauma 1991;31:406-11.
61. Tadokoro K, Ohioshi T, Takafuji S, Nakajima K, Suzuki S, Yamamoto K, Ito K, Miyamoto T, Muranaka M. Topical thrombin induced IgE mediated anaphylaxis: RAST analysis and skin test studies. J Allergy Clin Immunal 1991;66:620-9.
62. Nichols W.L, O'Marcaigh A.S, Daniels T.M, Fisher P.K, Gilchrist G.S. Incidence of immune-mediated coagulophathies associated with surgical use of fibrin sealant ("Glue") or bovine topical thrombin. (abst.) Thromb Haemost 1997; in press
63. Barninger H, Hardegger T, Tobler A, Barth A, Schupbach P, Reinhart W, Lammie B, Furlan M. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 1993;35:528-32.
64. Ortel TL, Charles LA, Keller FG, Marcoom PK, Oldham HN, Kane WH, Macik BG. Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis. Am J Hematol 1994;45:128-35.
65. Rapaport ST, Zivelin A, Minow RA, Hunter SH, Donnelly K: Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Am J Clin Pathol 1992;97:84-91.
66. Sheppard BB, Virgilio C, Bleiweis M, Milliken JC, Robertson JM. Inhibition of intra-abdominal adhesions: fibrin glue in a long-term model. Am Surg 1993;59:786-90.
67. Kovacs EJ, Albala DM, Dries DJ, Jahoda AE. Fibrin sealant inhibits peritoneal adhesion formation.(abst.) Thromb Haemost 1997; in press
68. Taguchi Y, Suzuki R, Okada M, Sekino H. Spinal arachnoid cyst developing after surgical treatment of a reptured vertebral artery aneurysm: a possible complication of topical use of fibrin glue. J Neurosurg 1996,84:526-9.
69. Dascombe W, Dumanian G, Hong C, Heil B, Labadie K, Hessel B, Blomback B, Johnson P. Application of thrombin based glue and non thrombin based batroxobin glue on intact human blood vessels and at vascular anastomoses: evidence for transmural delivery and procoagulant effect. Thromb Haemost 1997. Accepted for publication.
70. Pusateri A, Holcomb J, Harris R, Gomez R, Hetz S, MacPhee M, Enriquez J, Hess J, Beaumont W. Hemodynamic effect of intravenous bovine or human thrombin in swine. (abst.) Thromb Haemost 1997; in press.